YM443 + Placebo + Moxifloxacin
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Functional Dyspepsia
Conditions
Functional Dyspepsia
Trial Timeline
Feb 1, 2009 → Apr 1, 2009
NCT ID
NCT00850746About YM443 + Placebo + Moxifloxacin
YM443 + Placebo + Moxifloxacin is a phase 1 stage product being developed by Astellas Pharma for Functional Dyspepsia. The current trial status is completed. This product is registered under clinical trial identifier NCT00850746. Target conditions include Functional Dyspepsia.
What happened to similar drugs?
0 of 6 similar drugs in Functional Dyspepsia were approved
Approved (0) Terminated (1) Active (5)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00850746 | Phase 1 | Completed |
Competing Products
20 competing products in Functional Dyspepsia